Page last updated: 2024-11-04

sb 239063 and Bronchial Hyperreactivity

sb 239063 has been researched along with Bronchial Hyperreactivity in 2 studies

SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.

Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.

Research Excerpts

ExcerptRelevanceReference
"Bronchial asthma is a chronic inflammatory disorder of the airway accompanied by increased vascular permeability."1.38Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease. ( Jeon, MS; Kim, SR; Lee, KS; Lee, YC; Park, SJ, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SR2
Lee, KS2
Park, SJ2
Min, KH1
Lee, MH1
Lee, KA1
Bartov, O1
Atlas, D1
Lee, YC2
Jeon, MS1

Other Studies

2 other studies available for sb 239063 and Bronchial Hyperreactivity

ArticleYear
A novel dithiol amide CB3 attenuates allergic airway disease through negative regulation of p38 mitogen-activated protein kinase.
    American journal of respiratory and critical care medicine, 2011, Apr-15, Volume: 183, Issue:8

    Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Dis

2011
Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease.
    Journal of clinical immunology, 2012, Volume: 32, Issue:3

    Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Dise

2012